View in EDS PDF Full Text

Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.

Saved in:
Bibliographic Details
Title: Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab.
Authors: Dunn, E F1, Iida, M1, Myers, R A1, Campbell, D A1, Hintz, K A1, Armstrong, E A1, Li, C1, Wheeler, D L1
Source: Oncogene. 2/3/2011, Vol. 30 Issue 5, p561-574. 14p.
Database: Academic Search Ultimate
Description
ISSN:09509232
DOI:10.1038/onc.2010.430